Many GI Cancer Hospitalizations Are Avoidable

Share this content:
Many GI Cancer Hospitalizations Are Avoidable
Many GI Cancer Hospitalizations Are Avoidable

(HealthDay News) — For patients with advanced gastrointestinal (GI) cancer, about 20% of hospitalizations are potentially avoidable, according to a study published online Jan. 13 in the Journal of Clinical Oncology.

Gabriel A. Brooks, MD, and colleagues from the Dana-Farber Cancer Institute in Boston, and colleagues conducted a retrospective study to identify and characterize potentially avoidable hospitalization in patients with GI malignancies. A total of 201 hospitalizations were included for 154 unique patients (median age, 62 years) admitted to an inpatient medical oncology or palliative care service between December 2011 and July 2012.

The researchers found that the most common diagnosis was colorectal cancer (32%) and that most hospitalized patients (81%) had metastatic disease. More than half of hospitalizations (53%) were due to cancer symptoms and more than one-quarter (28%) were due to cancer treatment complications. Nineteen percent of hospitalizations were considered potentially avoidable by medical oncologists. 

Related: Gastrointestinal Cancers Resource Center

Potentially avoidable hospitalizations were more likely among patients aged ≥70 years (odds ratio [OR], 2.63); those who had received advice from an oncologist to consider hospice (OR, 6.09); and those who had received three or more lines of chemotherapy (OR, 2.68). Higher 90-day mortality was observed after avoidable hospitalizations versus non-avoidable hospitalizations (OR, 6.4).

"Potentially avoidable hospitalizations are common in patients with advanced GI cancer," the researchers wrote. "The majority of potentially avoidable hospitalizations occurred in patients with advanced treatment-refractory cancers near the end of life."

References

  1. Brooks GA, Abrams TA, Meyerhardt JA, et al. Identification of Potentially Avoidable Hospitalizations in Patients With GI Cancer. J Clin Oncol. 2014;10.1200/JCO.2013.52.4330.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs